Previously known as the Risk Evaluation and Mitigation Strategies Summit, the Fierce Drug Safety Summit will allow large, medium, and small-sized pharma, biotechs, and device companies to learn how to better perform their drug safety processes. Attendees will learn best practices and be better equipped to meet government regulations, ensuring the safety of their patients.
We will address the strategic and operational challenges faced by drug and patient safety teams and will feature two tracks dedicated to professionals responsible for REMS and Pharmacovigilance at pharma and biotech companies.
Thought leaders in risk evaluation/mitigation strategies and pharmacovigilance will share their knowledge and experience on current topics, including:
• Ensuring patient safety
• Navigating global regulations
• Working with limited vendor pools
• Managing safety risk management
Fierce Drug Safety Summit: USD 795.0
Time: 08:30 - 15:20